Sarepta Therapeutics
SRPT
#1400
Rank
$12.27 B
Marketcap
$130.74
Share price
0.39%
Change (1 day)
-0.31%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Net assets

Net assets on the balance sheet as of December 2023 : $0.85 B

According to Sarepta Therapeutics 's latest financial reports the company has $0.85 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sarepta Therapeutics - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2023-12-31$0.85 B123.23%
2022-12-31$0.38 B-58.52%
2021-12-31$0.92 B21.82%
2020-12-31$0.76 B-6.9%
2019-12-31$0.81 B-20.74%
2018-12-31$1.03 B30.8%
2017-12-31$0.78 B134.4%
2016-12-31$0.33 B76.88%
2015-12-31$0.19 B-23.14%
2014-12-31$0.24 B0.19%
2013-12-31$0.24 B99.87%
2012-12-31$0.12 B298.75%
2011-12-31$31.01 M-1201.06%
2010-12-31$-2.82 M-111.92%
2009-12-31$23.63 M50.2%
2008-12-31$15.73 M-40.37%
2007-12-31$26.38 M-30.04%
2006-12-31$37.71 M-29.72%
2005-12-31$53.66 M104.27%
2004-12-31$26.26 M-39.46%
2003-12-31$43.39 M84.8%
2002-12-31$23.48 M-23.1%
2001-12-31$30.53 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$22.74 B 2,547.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.82 B-195.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.72 B-183.43%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.23 B-125.68%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.34 B-138.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.46 B-153.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.50 B-41.73%๐Ÿ‡บ๐Ÿ‡ธ USA